This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Farmalider, S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ester Duart González: Innovator in Pain Relief Solutions
Introduction
Ester Duart González is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in pain management. Her innovative approach combines established medications to enhance their effectiveness in treating pain.
Latest Patents
Ester holds a patent for a unique combination of ibuprofen and tramadol for relieving pain. This invention relates to the use of ibuprofen in the form of a pharmaceutically acceptable salt, combined with tramadol or a pharmaceutical acceptable salt thereof. The specific dosages are crucial, with ibuprofen ranging between 350 mg and 450 mg and tramadol between 35 mg and 40 mg, expressed as the equivalent weight of tramadol hydrochloride. This combination is particularly effective for treating moderate to severe pain, whether of chronic or acute origin, and is designed for patients experiencing intense pain. Additionally, her patent includes a pharmaceutical composition comprising this fixed-dose combination.
Career Highlights
Ester is associated with Farmalider, S.A., where she continues to develop innovative solutions in the pharmaceutical industry. Her work focuses on improving pain relief methods, which has a significant impact on patient care.
Collaborations
Ester collaborates with notable colleagues, including Antonio Portolés Pérez and Luis Narciso Santé Serna. Their teamwork fosters an environment of innovation and shared expertise in the pharmaceutical field.
Conclusion
Ester Duart González is a trailblazer in the development of pain relief solutions, with her patent showcasing her commitment to enhancing patient care. Her contributions to the pharmaceutical industry are invaluable, and her work continues to influence the treatment of pain.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile